Evidence Hub

F-18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease

Patel CN, Smith JT, Rankine JJ, Scarsbrook AF

Clinical nuclear medicine, 2009

Abstract

A 20-year-old woman underwent magnetic resonance imaging of the spine for back pain, which demonstrated a solitary lesion in the T2 vertebral body suspicious for a metastasis. Subsequent computed tomography and bone scintigraphy identified several further sites of bony involvement but no primary malignancy. The patient was referred for F-18 FDG PET/CT which demonstrated intense FDG activity in the sternoclavicular and sacroiliac joints, in addition to the known thoracic vertebral body involvement suggesting spondyloarthropathy rather than malignant disease. During the course of investigations, the patient developed palmoplantar pustulosis leading to a diagnosis of SAPHO syndrome.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free